491
Participants
Start Date
April 25, 2018
Primary Completion Date
February 8, 2022
Study Completion Date
July 27, 2023
Irinotecan liposome injection
IV
Topotecan
IV
National Taiwan University Hospital, Taipei
Chang Gung Memorial Hospital, Linkou, Taoyuan District
Border Medical Oncology Research Unit, Albury
South West Healthcare, Warrnambool
North Shore Hematology Oncology Associates, PC, East Setauket
Roswell Park Cancer Institute, Buffalo
University of Maryland Medical Group, Baltimore
Pius-Hospital Oldenburg, Oldenburg
Hospital Universitario 12 de Octubre, Madrid
Hospital Regional Universitario de Malaga, Málaga
Charleston Hematology Oncology Associates, PA, Charleston
Greenville Hospital System University Medical Center, Greenville
Northwest Georgia Oncology Centers, Marietta
Cancer Treatment Centers of America-Georgia, Newnan
General Hospital Uzice, Užice
Florida Cancer Specialists, St. Petersburg
Florida Cancer Specialists (South Region), Fort Myers
Tennessee Oncology, Nashville
Communal Enterprise Kremenchuk Regional Oncology Dispensary of Poltava Regional Council, Kremenchuk
Hospital Universitario Virgen del Rocio, Seville
Case Western Reserve University, Cleveland
Tri County Hematology & Oncology Associates, Inc, Massillon
Hospital Universitari i Politecnic La Fe, Valencia
Henry Ford Hospital, Detroit
Sparrow Regional Cancer Center, Lansing
Cancer & Hematology Centers of Western Michigan, Grand Rapids
Evangelisches Krankenhaus Hamm GmbH, Hamm
Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv
Illinois Cancer Care, PC, Peoria
Universitaetsklinikum Heidelberg, Heidelberg
University of Oklahoma Health Sciences Center, Oklahoma City
Universitaetsklinikum Freiburg, Freiburg im Breisgau
National Jewish Health, Denver
Rocky Mountain Cancer Centers, Denver
CCCH City Oncological Center SHEI Uzhgorod NU, Uzhhorod
MultiCare Health System Institute for Research and Innovation, Spokane
Summit Cancer Treatment Center, Spokane
Beijing Cancer Hospital, Beijing
"SBHI of Kaluga Region Kaluga regional clinical oncology dispensary", Saint Petersburg
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Zhejiang Cancer Hospital, Hangzhou
Tongji Hospital, Hubei
The First Hospital of Jilin University, Changchun
Guangdong Provincial People's Hospital, Guangzhou
West China Hospital, Sichuan University, Chengdu
Southern Maine Health Care, Biddeford
Southern Medical Day Care Centre, Wollongong
Princess Alexandra Hospital, Woolloongabba
AZ Klina, Brasschaat
UZ Leuven, Leuven
Centre Hospitalier de l'Ardenne, Libramont
AZ Sint-Maarten, Mechelen
Hospital de Cancer de Barretos, Fundacoa Pio X II, Barretos
Hospital de Caridade de Ijuí, Ijuí
Oncobio Servicos de Saude, Nova Lima
HGB - Hospital Giovanni Battista - Mãe de Deus Center, Porto Alegre
Hospital Nossa Senhora da Conceição, Porto Alegre
INCA - Instituto Nacional de Câncer, Rio de Janeiro
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto
Linyi Cancer Hospital, Linyi
Henan Cancer Hospital, Zhengzhou
CHU Brest - Hôpital Morvan, Brest
Hôpital Nord - CHU Marseille, Marseille
Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez
Semmelweis Egyetem, Budapest
Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok
Tudogyogyintezet Torokbalint, Törökbálint
Zala Megyei Szent Rafael Korhaz, Zalaegerszeg
Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Azienda Sanitaria Universitaria Integrata di Udine, Udine
KO-MED Centra Kliniczne Biala Podlaska, Biała Podlaska
Szpitale Pomorskie spółka z ograniczoną odpowiedzialnością, Gdynia
SP Zespol Gruzlicy i Chorob Pluc w Olsztynie, Olsztyn
Przychodnia Med-Polonia Sp. z o.o., Poznan
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego, Poznan
S.C Gral Medical S.R.L, Bucharest
"Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca", Cluj-Napoca
S.C Medisprof S.R.L, Cluj-Napoca
S.C Centrul de Oncologie Sf. Nectarie S.R.L, Craiova
S.C Radiotherapy Center Cluj S.R.L, Floreşti
Oncomed SRL, Timișoara
"SBIH of Arkhangelsk region Arkhangelsk Clinical Oncological Dispensary", Arkhangelsk
"VitaMed LLC", Moscow
"BHI of Omsk region Clinical Oncology Dispensary", Omsk
"SPb SBIH City Clinical Oncological Dispensary", Saint Petersburg
"SBIH of Yaroslavl region Regional Clinical Oncological Hospital", Yaroslavl
"Clinical Center Bezanijska kosa", Belgrade
Clinical Center Kragujevac, Belgrade
Oncomed System, Belgrade
Institute for Pulmonary Diseases of Vojvodina, Kamenitz
Chungbuk National University Hospital, Cheongju-si
Asan Medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
The Catholic University of Korea, St. Vincent's Hospital, Suwon
Hospital General Universitario de Alicante, Alicante
Hospital General Universitario Gregorio Marañon, Madrid
Changhua Christian Hospital, Changhua
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Tri-Service General Hospital, Taipei
Baskent University Adana Application and Research Center, Adana
Trakya University Medical Faculty, Edirne
Istanbul Medeniyet Uni Goztepe Training&Res Hosp, Istanbul
Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Istanbul
Inonu Uni. Med. Fac., Malatya
Namik Kemal University, Tekirdağ
CI Chernivtsi RC Oncological Dispensary, Chernivtsi
CI Dnipropetrovsk CMCH #4 of Dnipropetrovsk RC Dept of Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipro
CI Kryvyi Rih Oncological Dispensary of DRC, Kryvyi Rih
Treatment-Prevention Institution Volyn Regional Oncological Dispensary, Lutsk
Odesa Regional Oncologic Dispensary, Odesa
RCI Sumy Regional Clinical Oncological Dispensary, Sumy
Centre Hospitalier de Saint-Quentin, Saint-Quentin
ICO l'Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Hospital Universitari Vall d'Hebron, Barcelona
Medical Clinic Innovacia, LLC, Vyshhorod
Lead Sponsor
Ipsen
INDUSTRY